Patent · US Expired

Recombinant poxvirus host range selection system

US5225336A · kind A · utility

126Cited by
0References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 23, 1992
Grant dateJul 6, 1993
Priority date
Expiry dateJun 23, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/20122
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

What is described is a modified recombinant virus for expressing a gene product in a host. The modified recombinant virus has host range genes deleted therefrom so that the virus has restricted replication in the host. The modified recombinant virus also contains DNA which codes for and expresses the gene product in the host even with restricted replication of the virus in the host. The modified recombinant virus is used in a method for expressing a gene product in a host or in a cell cultured in vitro, and in a vaccine for inducing an immunological response in a host inoculated with the vaccine. What is also described is a selection system for the cloning and expression of open reading frames in poxviruses, particularly vaccinia virus. The selection system is based on a con This invention was made with Government support under contract DAMD17-85-C-5232 awarded by the Department of the Army. The Government has certain rights in this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.